United States Steel Co. (NYSE:X) Director Tracy A. Atkinson acquired 1,468 shares of the stock in a transaction dated Tuesday, February 16th. The shares were purchased at an average price of $17.07 per share, for a total transaction of $25,058.76. Following the completion of the transaction, the director now owns 17,177 shares of the company's stock, valued at approximately $293,211.39. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
United States Steel stock opened at $17.86 on Thursday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 1.54 and a current ratio of 2.30. The firm has a market cap of $3.94 billion, a P/E ratio of -1.76 and a beta of 2.39. The business's fifty day moving average is $18.80 and its two-hundred day moving average is $12.49. United States Steel Co. has a 52 week low of $4.54 and a 52 week high of $24.71.
United States Steel (NYSE:X) last posted its quarterly earnings data on Wednesday, January 27th. The basic materials company reported ($0.27) EPS for the quarter, topping analysts' consensus estimates of ($0.68) by $0.41. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.51 billion. United States Steel had a negative return on equity of 18.78% and a negative net margin of 16.25%. The business's revenue was down 9.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.64) earnings per share. On average, equities research analysts predict that United States Steel Co. will post -5.57 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 9th. Stockholders of record on Monday, February 8th will be given a dividend of $0.01 per share. The ex-dividend date is Friday, February 5th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.22%. United States Steel's payout ratio is currently 44.44%.
Several analysts recently commented on X shares. Argus raised United States Steel from a "hold" rating to a "buy" rating and set a $22.00 price target on the stock in a research note on Wednesday, December 9th. Zacks Investment Research lowered United States Steel from a "buy" rating to a "hold" rating and set a $25.00 price target on the stock. in a research note on Wednesday, January 13th. TheStreet raised United States Steel from a "d" rating to a "c-" rating in a research note on Friday, January 29th. Deutsche Bank Aktiengesellschaft raised United States Steel from a "sell" rating to a "buy" rating in a research note on Friday, January 8th. Finally, Cfra raised United States Steel from a "strong sell" rating to a "hold" rating in a research note on Friday, October 30th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of "Hold" and a consensus price target of $11.63.
Several hedge funds have recently added to or reduced their stakes in the company. Truist Financial Corp raised its position in shares of United States Steel by 126.9% during the fourth quarter. Truist Financial Corp now owns 25,171 shares of the basic materials company's stock worth $422,000 after acquiring an additional 14,077 shares during the last quarter. SummerHaven Investment Management LLC bought a new stake in shares of United States Steel during the fourth quarter worth $1,023,000. Stansberry Asset Management LLC bought a new stake in shares of United States Steel during the fourth quarter worth $16,383,000. Voloridge Investment Management LLC raised its position in shares of United States Steel by 144.1% during the fourth quarter. Voloridge Investment Management LLC now owns 2,270,120 shares of the basic materials company's stock worth $38,070,000 after acquiring an additional 1,339,990 shares during the last quarter. Finally, Cetera Investment Advisers raised its position in shares of United States Steel by 14.2% during the fourth quarter. Cetera Investment Advisers now owns 13,065 shares of the basic materials company's stock worth $219,000 after acquiring an additional 1,624 shares during the last quarter. Institutional investors own 60.36% of the company's stock.
About United States Steel
United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe. It operates through three segments: North American Flat-Rolled (Flat-Rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment offers slabs, strip mill plates, sheets and tin mill products, as well as all iron ore and coke.
Featured Story: Diversification Important in Investing
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]7 Healthcare Stocks Delivering Innovation in 2021
We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.
Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.
However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.
That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.
View the "7 Healthcare Stocks Delivering Innovation in 2021"